Phase I/II Clinical Study of PRaG Regimen Combined with Intraperitoneal Infusion of PD-1 Inhibitor for Advanced Refractory Solid Tumors with Cancerous Ascites (prag4.0p Study)
TECHNOLOGY IN CANCER RESEARCH & TREATMENT（2024）
Key words
cancerous ascites,intraperitoneal infusion of PD-1 inhibitor,hypofractionated radiotherapy,immunotherapy,GM-CSF
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined